Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Amifostine with Radiotherapy for Head and Neck Cancer
NCT00003193Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 1998
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, amifostine in head and neck squamous cell carcinoma (HNSCC), sponsored by Massachusetts General Hospital. Started Jan 1998; status: completed.
02
Drugs
paclitaxelamifostine
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00003193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003193.